Impact of anemia on in-stent restenosis after percutaneous coronary intervention
Abstract Background Anemia is a common risk factor for post-percutaneous coronary intervention (PCI) adverse events; however, data on its association with in-stent restenosis (ISR) is limited. Methods 538 patients who underwent PCI between January 2017 and September 2019 and follow-up angiography 9–...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/15acce96d22848db8bb7bf197bce204a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:15acce96d22848db8bb7bf197bce204a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:15acce96d22848db8bb7bf197bce204a2021-11-21T12:04:15ZImpact of anemia on in-stent restenosis after percutaneous coronary intervention10.1186/s12872-021-02355-11471-2261https://doaj.org/article/15acce96d22848db8bb7bf197bce204a2021-11-01T00:00:00Zhttps://doi.org/10.1186/s12872-021-02355-1https://doaj.org/toc/1471-2261Abstract Background Anemia is a common risk factor for post-percutaneous coronary intervention (PCI) adverse events; however, data on its association with in-stent restenosis (ISR) is limited. Methods 538 patients who underwent PCI between January 2017 and September 2019 and follow-up angiography 9–12 months after the initial PCI were enrolled in this study. Baseline clinical and procedural characteristics were compared between the ISR and non-ISR groups, and independent predictors of ISR were determined using propensity score matching. Results The incidence of anemia was 53.5% in patients with ISR and 19.0% in those without ISR. Univariable logistic regression analyses showed that anemia (OR, 4.283; 95% CI, 1.949–9.410; P < 0.001), diabetes mellitus (OR, 2.588; 95% CI, 1.176–5.696; P = 0.018), chronic kidney disease (OR, 3.058; 95% CI, 1.289–7.252; P = 0.011), multiple stenting (OR, 2.592; 95% CI, 1.205–5.573; P = 0.015), bifurcation lesion (OR, 2.669; 95% CI, 1.236–5.763; P = 0.012), and calcification (OR, 3.529; 95% CI, 1.131–11.014; P = 0.030) were closely associated with ISR. Low-density lipoprotein cholesterol (LDL-c) levels and stent diameter were also significantly linked to ISR, as was anemia (P = 0.009) after propensity score matching. Conclusion Anemia is closely associated with post-PCI ISR, and patients with lower hemoglobin levels are at a higher risk of ISR.Huilin HuShijun WangGuanmin TangChanglin ZhaiLiang ShenBMCarticleAnemiaIn-stent restenosisPercutaneous coronary interventionDiseases of the circulatory (Cardiovascular) systemRC666-701ENBMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-7 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Anemia In-stent restenosis Percutaneous coronary intervention Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
Anemia In-stent restenosis Percutaneous coronary intervention Diseases of the circulatory (Cardiovascular) system RC666-701 Huilin Hu Shijun Wang Guanmin Tang Changlin Zhai Liang Shen Impact of anemia on in-stent restenosis after percutaneous coronary intervention |
description |
Abstract Background Anemia is a common risk factor for post-percutaneous coronary intervention (PCI) adverse events; however, data on its association with in-stent restenosis (ISR) is limited. Methods 538 patients who underwent PCI between January 2017 and September 2019 and follow-up angiography 9–12 months after the initial PCI were enrolled in this study. Baseline clinical and procedural characteristics were compared between the ISR and non-ISR groups, and independent predictors of ISR were determined using propensity score matching. Results The incidence of anemia was 53.5% in patients with ISR and 19.0% in those without ISR. Univariable logistic regression analyses showed that anemia (OR, 4.283; 95% CI, 1.949–9.410; P < 0.001), diabetes mellitus (OR, 2.588; 95% CI, 1.176–5.696; P = 0.018), chronic kidney disease (OR, 3.058; 95% CI, 1.289–7.252; P = 0.011), multiple stenting (OR, 2.592; 95% CI, 1.205–5.573; P = 0.015), bifurcation lesion (OR, 2.669; 95% CI, 1.236–5.763; P = 0.012), and calcification (OR, 3.529; 95% CI, 1.131–11.014; P = 0.030) were closely associated with ISR. Low-density lipoprotein cholesterol (LDL-c) levels and stent diameter were also significantly linked to ISR, as was anemia (P = 0.009) after propensity score matching. Conclusion Anemia is closely associated with post-PCI ISR, and patients with lower hemoglobin levels are at a higher risk of ISR. |
format |
article |
author |
Huilin Hu Shijun Wang Guanmin Tang Changlin Zhai Liang Shen |
author_facet |
Huilin Hu Shijun Wang Guanmin Tang Changlin Zhai Liang Shen |
author_sort |
Huilin Hu |
title |
Impact of anemia on in-stent restenosis after percutaneous coronary intervention |
title_short |
Impact of anemia on in-stent restenosis after percutaneous coronary intervention |
title_full |
Impact of anemia on in-stent restenosis after percutaneous coronary intervention |
title_fullStr |
Impact of anemia on in-stent restenosis after percutaneous coronary intervention |
title_full_unstemmed |
Impact of anemia on in-stent restenosis after percutaneous coronary intervention |
title_sort |
impact of anemia on in-stent restenosis after percutaneous coronary intervention |
publisher |
BMC |
publishDate |
2021 |
url |
https://doaj.org/article/15acce96d22848db8bb7bf197bce204a |
work_keys_str_mv |
AT huilinhu impactofanemiaoninstentrestenosisafterpercutaneouscoronaryintervention AT shijunwang impactofanemiaoninstentrestenosisafterpercutaneouscoronaryintervention AT guanmintang impactofanemiaoninstentrestenosisafterpercutaneouscoronaryintervention AT changlinzhai impactofanemiaoninstentrestenosisafterpercutaneouscoronaryintervention AT liangshen impactofanemiaoninstentrestenosisafterpercutaneouscoronaryintervention |
_version_ |
1718419228831252480 |